Where does Abbott Laboratories Vascular Enterprises Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abbott Laboratories Vascular Enterprises Limited ranks #14,419 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Abbott Laboratories Vascular Enterprises Limited's Innovation Score?

Abbott Laboratories Vascular Enterprises Limited has an Innovation Score of 33.5 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Abbott Laboratories Vascular Enterprises Limited's patent grant rate increasing or decreasing?

Abbott Laboratories Vascular Enterprises Limited's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Abbott Laboratories Vascular Enterprises Limited's patents?

Abbott Laboratories Vascular Enterprises Limited's patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Abbott Laboratories Vascular Enterprises Limited

Q: How many patents does Abbott Laboratories Vascular Enterprises Limited hold?

Abbott Laboratories Vascular Enterprises Limited holds 20 US utility patents granted between 2015 and 2019, spanning 13 technology areas.

Q: What technology areas does Abbott Laboratories Vascular Enterprises Limited focus on?

Abbott Laboratories Vascular Enterprises Limited's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 15 patents, ranking #428 of 3,082 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Q: How is the Abbott Laboratories Vascular Enterprises Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 20 granted patents across 13 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abbott ranks #14,419 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 13 technology areas.

#14,419
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.5/100): 17.1
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14419 · Foreign Corporation #14,419 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,419/49,997
PHOTO-FINISH Aalto University
CPC-FOCUS A61F · 13 areas
INNOV-THIN 33.5/100
CLAIMS-RICH 17.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aalto University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abbott’s 33.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (31%) Velocity 0.0 pts (0%) Breadth 12.7 pts (38%) Claim depth 10.3 pts (31%)

Qualcomm Incorporated · highest

85
Abbott Laboratories… · this assignee

34
3D Lighting… · lowest

7

What this shows Abbott's Innovation Score is 33.5/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abbott?

Each dot is one of Abbott’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abbott’s own 17.1 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Abbott vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abbott's grants concentrate

Abbott Laboratories Vascular Enterprises Limited is a focused PatentsView assignee: 13 CPC subclasses with 75% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (10 grants) versus a trough of 2 in 2017. By volume, Abbott sits between Attends Healthcare Products, Inc. and Aclaris Therapeutics, Inc..

Attends Healthcar…

20
Autoflight (Kunsh…

20
Aveo Pharmaceutic…

20
Aalto University

20
Abyrx

20
Accelerate Diagno…

20
Accutar Biotechno…

20
Aclaris Therapeut…

20
Abbott Laboratori… ◀

20

What this shows Abbott holds 20 patents at rank #14,444, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbott

By rank, the assignees closest to #14,444 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Abbott's primary technology class.

Abbott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abbott Laboratories Vascular Enterprises Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	30.0%
2016	10	50.0%
2017	2	10.0%
2019	2	10.0%

Which technologies does Abbott Laboratories Vascular Enterprises Limited patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 15

Y10T - Technical Subjects Covered BY Former US Classification 7

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

A61B - DIAGNOSIS; SURGERY; Identification 1

B24B - Machines, Devices, OR Processes FOR Grinding OR Polishing ; Dressing OR Conditioning OF Abrading SURFACES; Feeding OF Grinding, Polishing, OR Lapping Agents 1

B23B - TURNING; Boring 1

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 1

C25F - Processes FOR THE Electrolytic Removal OF Materials From OBJECTS; Apparatus Therefor 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Abbott Laboratories Vascular Enterprises Limited's patent record in context - here's where to go next.

Abbott Laboratories Vascular Enterprises Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 75% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #14,419 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abbott Laboratories Vascular Enterprises Limited against Attends Healthcare Products, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.